AXNX

Axonics, Inc.

68.17 USD
-0.22 (-0.32%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Axonics, Inc. stock is down -0.12% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 February’s closed higher than January. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
26 Dec 18:34 19 Jan, 2024 65.00 CALL 443 154
08 Jan 18:44 19 Apr, 2024 70.00 CALL 4756 31

About Axonics, Inc.

Axonics, Inc. engages in the development and commercialization of sacral neuromodulation (SNM) systems. SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinent.